Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

NCT01703481

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +29 more
Locations
  • Birmingham, Alabama, United States
  • Tucson, Arizona, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 37 locations
View Trial Details
Completed

Avelumab in First-line NSCLC (JAVELIN Lung 100)

NCT02576574

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Arizona Center for Cancer Care Surprise, Arizona, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • University Cancer Institute Boynton Beach, Florida, United States
View all 349 locations
View Trial Details
Completed

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

NCT03821233

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +44 more
Locations
  • City of Hope Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Medicine Chicago, Illinois, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 16 locations
View Trial Details
Completed

A Study to Assess Prevalence of a Specific Protein Overexpression in Adult Participants With Non-Small Cell Lung Cancer

NCT06068842

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital Italiano de Buenos Aires /ID# 256999 Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina
  • Instituto Alexander Fleming /ID# 256295 Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
  • Irmandade da Santa Casa de Misericordia de Porto Alegre /ID# 256487 Porto Alegre, Rio Grande do Sul, Brazil
  • Hospital Alemao Oswaldo Cruz /ID# 256486 São Paulo, Brazil
View all 19 locations
View Trial Details
Completed

Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M

NCT02841579

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • MedSIR Investigative Site A Coruña, Spain
  • MedSIR Investigative Site Barcelona, Spain
  • MedSIR Investigative Site Barcelona, Spain
  • MedSIR Investigative Site Bilbao, Spain
View Trial Details
Completed

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

NCT03674567

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +44 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles JCCC Clinical Research Unit Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 35 locations
View Trial Details
Completed

A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

NCT03285763

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Hospital Aleman Caba, Argentina
  • Centro Oncologico Riojano Integral (CORI) La Rioja, Argentina
  • CETUS Hospital Dia Oncologia Uberaba, Minas Gerais, Brazil
  • Hospital das Clinicas - UFRGS Porto Alegre, Rio Grande do Sul, Brazil
View all 111 locations
View Trial Details

Related conditions